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j ourna l homepage: www.e lsev ie r .com/ locate /c rwhInvited EditorialMultimorbidity in people living with dementiaH I G H L I G H T S• Multimorbidity is typical of the majority of people living with dementia.
• Healthcare systems are designed around single organ disease not multimorbidity.
• Guidelines for people with multimorbidity and dementia are hampered by a limited evidence base.
• Research to underpin new models of care is urgently needed.Keywords:
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Aging1. Introduction
Multimorbidity has been variably deﬁned but is generally taken to
refer to a situation where an individual has two or more long-term
health conditions. This working deﬁnition has been extended with the
National Institute for Health and Care Excellence (NICE), expanding
‘long-term health conditions’ [1] to include:
• deﬁned physical and mental health conditions
• ongoing conditions
• symptom complexes
• sensory impairments
Multimorbidity is important because it is associated with a poorer
quality of life and increased risks of mortality, polypharmacy, adverse
drug reactions, falls and hospital admissions. It is more common in
older people and in those living with socio-economic deprivation [1].
Multimorbidity already affects two-thirds of the UK population aged
over 65 and is projected to affect an even higher proportion. Despite
this, healthcare is still designed around single organ problems -
multimorbidity has implications for any re-organisation of health and
social care. The situation becomesmore challengingwhen an individual
has both physical and mental health conditions and where their health
complaints span this divide such as with dementia.
An estimated 50million people worldwidewere livingwith demen-
tia in 2018 and this is predicted to rise to 152million people by 2050 [2].
Multimorbidity is typical of themajority of people living with dementia
and in one UK observational study a mean of 4.6 comorbidities in addi-
tion to dementia were identiﬁed. Conditions such as falls, osteoarthritis,https://doi.org/10.1016/j.crwh.2019.e00125
2214-9112/© 2019 The Author. Published by Elsevier B.V. This is an open access article underdiabetes mellitus, stroke, osteoporosis and heart failure were highly
prevalent occurring in up to one-quarter of participants [3]. Dementia
is more common in older women than older men; largely due to
women living longer. Conditions such as osteoporosis, falls and frac-
tures are more common in women and are more common in people
with dementia. Indeed multimorbidity in general is more common in
people with dementia [4].
Despite the projected rise in multimorbidity and dementia surpris-
ingly little research has examined even the basic epidemiology of this
growing population [4]. Healthcare, functional and social support for
people with multiple health conditions is not straightforward and the
addition of cognitive impairment adds a further layer of complexity.
For future service development to best support the growing number
of people with these conditions the ﬁrst stage is to describe this popula-
tion and to understand the interaction between dementia and other
common comorbidities. Such an interaction is not simple and is highly
variable.
Dementia has a complex relationship with other long-term health
conditions which can result in a cumulative spiral of increasing risk
leading to an adverse outcome. For instance, dementia is a risk factor
for falls but also for osteoporosis - this results in a higher rate of frac-
tures thanmight be expected from the intrinsic falls rate alone. In addi-
tion dementia is also associated with poorer recovery from fractures
after the event; further compounding this issue [5]. Dementia alsomod-
iﬁes the natural history of highly prevalent conditions such as hyperten-
sion. In contrast to the general population, systolic blood pressure has
been observed to start falling up to 6 years before the development of
clinically apparent dementia [6] and to continue to fall thereafter. The
observed falls in blood pressure (of between 22 and 8 mmHg) have
been potentially sufﬁcient to move an individual below treatment
thresholds. This interaction therefore has implications for the treatment
andmonitoring of blood pressure in peoplewith dementia compared to
the cognitively intact population [7].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2 Invited EditorialPerson-led care has been a central element of NHS planning since
the 1990s - seen as a key mechanism to improve the quality of care
for people living with long term health conditions [8]. The NICE
multimorbidity guidance advocates an individually tailored, goal driven
approach with the aim of personalising care to match the aims of an in-
dividual patient. The guidance acknowledges that the management of
multimorbidity (already far from simple) is more complicated in the
presence of dementia and stresses a careful consideration of the beneﬁts
and harms of any interventions. However, the guidance is hampered by
the historic exclusion of people with dementia frommultiple trials. This
extends to trials of self-management of long-term health conditions
where the only identiﬁed study to include people with dementia was
considered to have poor quality evidence [1]. The treatment goals of
an individual with dementia may change over the course of their cogni-
tive diagnosis. Thus when mildly impaired, preventative medications
such as antihypertensives may be desired, but in later stages of the dis-
ease treatments which prioritise quality of life over quantity may be
more valued. People living with dementia and multimorbidity may
therefore be trying to weigh up the beneﬁts and harms of a treatment
in the absence of a robust evidence base in a situation where their
own goals may change with time and where their capacity to make
such a decision may become blurred.
2. Conclusion
In the coming years therewill be a growing population of people liv-
ing with dementia and multimorbidity. Multimorbidity is already the
majority lived experience of those aged over 65 in the UK and service
provision is struggling to adapt to this situation despite multiple re-
organisations of healthcare provision.
For themajority of practitioners it is now self-evident thatmanaging
multimorbidity should be person-centred and goal driven. The potential
beneﬁts and harms of pharmacological and non-pharmacological inter-
ventions should be discussed and compared as part of routine care. Such
conversations are not without difﬁculty - the capacity to make such a
treatment decision, the treatment goal and perceived beneﬁts and
harms may change with time and this will continue to be an issue in
supporting people with dementia. However, the chief difﬁculty in
such discussions, and I would argue part of the reason for the slow ad-
aptation of the healthcare system to this challenge, is the lack of evi-
dence base particularly for those living with dementia.
To support the development of appropriate healthcare systems, to
support practitioners caring for people with dementia and
multimorbidity and to support the people themselves it is now essential
for a ﬁrm evidence base to be developed. The ﬁrst stage must be to gain
a more robust understanding of the functional, cognitive and medical
impairments experienced by people with dementia. In part this could
be carried out through large scale epidemiological studies using big
data but it also requires a more personalised approach with detailed
phenotyping of a cohort of people living with cognitive impairment.Such information could then help underpin the urgently needed evi-
dence base to support better clinical decision making and systems de-
sign for people with multimorbidity and dementia.
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